Skip to main content

Table 1 Impact of adjuvant chemotherapy on reducing annual odds of recurrence and death

From: Dose-dense adjuvant chemotherapy for primary breast cancer

Comparison (n)

Recurrence

Death

CMF versus nil (8150)

+24 ± 3

+14 ± 4

CMF+ versus nil (3218)

+20 ± 5

+15 ± 5

Anthracyclines+ versus CMF (6950)

+12 ± 4

+11 ± 5

Longer versus shorter (6104)

+7 ± 4

-1 ± 5

  1. Values are expressed as percentage ± standard deviation. Data from Early Breast Cancer Trialists' Collaborative Group [3]. CMF, cyclophosphamide, methotrexate and 5-fluorouracil.